See also this year's filing and all EDGAR filings for this company.
PDF Report 0001335105_2026_Lixte_Biotechnology_Holdings_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001335105, Lixte Biotechnology Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,178,379 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,582,560 |
| 3 | remainder_Assets | 972,682 |
| 4 | LiabilitiesCurrent | 1,333,111 |
| 5 | LiabilitiesNoncurrent | 438,959 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,849,329 |
| 9 | ResearchAndDevelopmentExpense | 185,950 |
| 10 | remainder_Expenses | 712,358 |
| 11 | remainder_Revenues | 3,738 |
| 12 | remainder_NetIncome | 6,452 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,733,621 |
| 1 | Liabilities | 1,772,070 |
| 2 | Expenses | 5,747,637 |
| 3 | Revenues | 3,738 |
| 4 | StockholdersEquity | 10,961,551 |
| 5 | NetIncome | -5,737,447 |
| 6 | ComprehensiveNetIncome | -5,737,447 |
| 7 | BaseVar | 10,131,759 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.50 |
| 9 | EconomicCapitalRatio | 3.36 |
Edgar->Model Mapping
Feature Distribution
Change over Time
